• CLS resolved a directed issue of 777,624 TO 9 B warrants to Vator Securities at no cost.
• Each TO 9 B warrant entitles holders to subscribe for one new B-share at SEK 1.9.
• Exercise window runs from March 1, 2027 to March 15, 2027.
• First trading day for TO 9 B warrants set for Sept. 9, 2026; last trading day expected March 11, 2027.
• Total TO 9 B warrants outstanding to rise to 13,012,236.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CLS - Clinical Laserthermia Systems AB published the original content used to generate this news brief via Cision (Ref. ID: 20260903:BIT:6054:0) on September 03, 2026, and is solely responsible for the information contained therein.